 Tyme Technologies Inc NASDAQ: TYME shares are nearly doubling on above-average volume Wednesday. Tyme, which focuses on developing cancer metabolism-based therapies, said the U.S. Patent and Trademark Office has granted additional patent claims related to its metabolomic technology platform. 